|
| |
VIRxSYS CorporationVIRxSYS Corporation is a privately held biotech company. The Company was founded in 1998 and is located in the biotech corridor of Gaithersburg, Maryland. Using technology first developed by and exclusively licensed from The Johns Hopkins University, VIRxSYS has developed a gene delivery system (a vector) from a human lentivirus for the treatment of serious diseases such as HIV/AIDS and cancer.
With the successful development of numerous genetic and therapeutic payloads, there have been great promises of genetic medicine. However, most of these promises have been unfulfilled because of the medical industry's inability to develop a transport system to deliver the genetic and therapeutic payloads into targeted cells efficiently, reproducibly and permanently.
Today this is no longer an issue, as VIRxSYS has solved this final hurdle that will now allow the promises of genetic medicine to become a reality. Payloads delivered by other vectors previously and currently used have serious drawbacks, while payloads delivered via VIRxSYS' lentiviral vector (i) have staying power within a cell because the payloads become a permanent part of the cell's genetic material, (ii) have a 95%+ delivery efficiently compared to approximately 20% to 50% for other viral vectors, (iii) can reproduce this delivery efficiently under optimal and sub optimal conditions.
| Contact Details: |
| 200 Perry Parkway, Suite 1A |
| Gaithersburg |
| Maryland |
| 20877 |
| United States of America |
| Tel: | 301.987.0480 |
| Fax: | |
| Email: | findout@virxsys.com |
| WWW: | www.virxsys.com/
|
|
Loading...
|
Recent Publications by VIRxSYS Corporation: |  |
Lentiviral vectors in clinical trials: Current status.
Lentiviral vectors (LVs) are the most recently developed viral-derived... | 7th October, 2009
| VIRxSYS Corp, Gaithersburg, MD 20877, USA.
| Curr Opin Mol Ther. 2009 Oct;11(5):554-64.
|
Lentiviral vectors for HIV disease prevention and treatment.
HIV/AIDS has posed major challenges to the scientific community, both in... | 23rd July, 2009
| VIRxSYS Corporation, 200 Perry Parkway, Gaithersburg, MD 20877, United
| Vaccine. 2009 May 26;27(25-26):3443-9. Epub 2009 Feb 6.
DOI Direct Link |
Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo.
Spliceosome-mediated RNA trans-splicing has emerged as an exciting mode of... | 7th April, 2009
| VIRxSYS Corporation, Gaithersburg, Maryland, USA.
| Mol Ther. 2009 Feb;17(2):343-51. Epub 2008 Dec 9.
DOI Direct Link |
Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
BACKGROUND: A stable packaging cell line facilitates large-scale... | 27th August, 2005
| VIRxSYS Corporation, Gaithersburg, Maryland 20877 [correction] USA.
| J Gene Med. 2005 Jun;7(6):818-34.
DOI Direct Link |
Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector.
This review is intended to exemplify the roles and responsibilities of the... | 1st June, 2005
| VIRxSYS, 200 Perry Parkway,
| Hum Gene Ther. 2005 Jan;16(1):17-25.
DOI Direct Link |
→View more VIRxSYS Corporation research publications. |
Press Releases on VIRxSYS Corporation:
|
 |
| VIRxSYS Publishes New Study on RNA Therapy |
6th April, 2009 |
VIRxSYS Corporation |
New RNA therapy reversed hemophilia in mice
GAITHERSBURG, Md., April 6 /PRNewswire/ -- VIRxSYS Corporation announced today the publication of a new research article, "Trans-splicing into Highly
|
| VIRxSYS to Host a Web Conference to Announce Clinical Trial Update |
21st July, 2008 |
VIRxSYS Corporation |
GAITHERSBURG, Md., July 21 /PRNewswire/ -- VIRxSYS Corporation, a
privately held company developing gene therapies for HIV and genetic diseases,
will present an update on the VRX496 Phase I and
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 688 times since April 2007, the link to the organisation's website has been followed 117 times Recent Search Terms used to find this page: virxsys funding | virxsys 2009 | virxsys | virxsys | biotech corridor gaithersburg | virxsys vih 2009 | VIRxSYS Gaithersburg MD | virxsys funding | VIRxSYS | Virxsys | . Search for more companies in Gaithersburg Search for more companies in Maryland This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for VIRxSYS Corporation |
